| Print
Applied Therapeutics (APLT)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Applied Therapeutics Inc Annual Report for 2025 | 2026-04-15T00:00:00 |
| Applied Therapeutics Inc Fourth Quarter Earnings Results for 2025 | 2026-04-14T00:00:00 |
| Applied Therapeutics Inc Third Quarter Earnings Results for 2025 | 2025-11-07T00:00:00 |
| Applied Therapeutics Inc Second Quarter Earnings Results for 2025 | 2025-08-07T00:00:00 |
| Applied Therapeutics Inc Annual General Meeting for 2025 | 2025-06-06T10:00:00 |
| Applied Therapeutics Inc First Quarter Earnings Results for 2025 | 2025-05-09T00:00:00 |
| Applied Therapeutics Inc Annual Report for 2024 | 2025-04-15T00:00:00 |
| Applied Therapeutics Inc Fourth Quarter Earnings Results for 2024 | 2025-04-14T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Applied Therapeutics Inc Annual Report for 2024 | 2025-04-15T00:00:00 |
| Applied Therapeutics Inc Fourth Quarter Earnings Results for 2024 | 2025-04-14T00:00:00 |
| 2024 UBS Global Healthcare Conference | 2024-11-12T07:15:00 |
| Applied Therapeutics Inc Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
| 2024 cantor global healthcare conference | 2024-09-18T10:20:00 |
| Baird 2024 global healthcare conference | 2024-09-10T15:45:00 |
| Applied Therapeutics Inc Second Quarter Earnings Results for 2024 | 2024-08-07T00:00:00 |
| Applied Therapeutics Inc Annual General Meeting for 2024 | 2024-06-06T10:00:00 |
| Applied Therapeutics will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference | 2024-05-14T16:35:00 |
| Applied Therapeutics Inc First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.